Your browser doesn't support javascript.
loading
Effect of acetyl-L-carnitine on Vip-ergic neurons in the jejunum submucous plexus of diabetic rats
Defani, Marli Aparecida; Zanoni, Jacqueline Nelisis; Natali, Maria Raquel Marçal; Bazotte, Roberto Barbosa; Miranda-Neto, Marcílio Hubner de.
  • Defani, Marli Aparecida; State University of Maringá. Departament of Sciences. Maringá. BR
  • Zanoni, Jacqueline Nelisis; State University of Maringá. Department of Morphophysiological Sciences. Maringá. BR
  • Natali, Maria Raquel Marçal; State University of Maringá. Department of Morphophysiological Sciences. Maringá. BR
  • Bazotte, Roberto Barbosa; State University of Maringá. Department of Pharmacy and Pharmacology. Maringá. BR
  • Miranda-Neto, Marcílio Hubner de; State University of Maringá. Department of Morphophysiological Sciences. Maringá. BR
Arq. neuropsiquiatr ; 61(4): 962-967, Dec. 2003. ilus, tab, graf
Article Dans En | LILACS | ID: lil-352434
Responsable en Bibliothèque : BR1.1
ABSTRACT
The effect of the treatment with acetyl-L-carnitine (ALC) on neurons releasing the vasoactive intestinal polypeptide (VIP) of the submucous plexus in the jejunum of diabetic rats was the purpose of our investigation. Diabetes (DM) was induced by injecting streptozotocin endovenously (35mg/kg). After sacrificing the animals, the jejunum was collected and processed for VIP detection. Four groups were used C (non-diabetic), CC (non-diabetic treated with ALC), D (diabetic), DC (diabetes treated with ALC). We analyzed the immunoreactivity and the cellular profile of 126 cell bodies. The treatment with ALC improved some aspects of DM. However, it promoted a small increase in the area of neurons from group CC, suggesting a possible neurotrophic effect. Neurons from groups D and DC showed a large increase in their cellular profile and immunoreactivity when compared to C and CC, suggesting a larger concentration of this neurotransmitter within the neurons that produce it. This observation constitutes a recurrent finding in diabetic animals, suggesting that ALC doesnot interfere in the pathophysiological mechanisms that unchain a higher production and/or neurotransmitter accumulation and increase the profile of the VIP-ergic neurons
Sujets)
Texte intégral: 1 Indice: LILACS Sujet Principal: Acétyl-carnitine / Plexus nerveux sous-muqueux / Peptide vasoactif intestinal / Nootropiques / Diabète expérimental / Jéjunum / Neurones Limites du sujet: Animals langue: En Texte intégral: Arq. neuropsiquiatr Thème du journal: NEUROLOGIA / PSIQUIATRIA Année: 2003 Type: Article
Texte intégral: 1 Indice: LILACS Sujet Principal: Acétyl-carnitine / Plexus nerveux sous-muqueux / Peptide vasoactif intestinal / Nootropiques / Diabète expérimental / Jéjunum / Neurones Limites du sujet: Animals langue: En Texte intégral: Arq. neuropsiquiatr Thème du journal: NEUROLOGIA / PSIQUIATRIA Année: 2003 Type: Article